Life sciences & medtech advisory · Australia

Every company has
a point where its
trajectory bends.
We work there.

Keyflexion provides expertise as a service to founders, boards, investors and leadership teams in life sciences and medtech. Senior operators and dealmakers — real-world commercialisation, deal-making and boardroom judgement. You work with the owners, not juniors.

The firm

What sets us apart is that we’ve actually done it.

Keyflexion partners with founders, boards, investors and leadership teams to navigate the path from innovation to commercial success — as chief executives, operators, finance leaders and board directors. Each principal brings several disciplines rather than a single specialism, so you get senior judgement across science, commercial, capital and governance from the same small team, and you deal directly with the people doing the work.

Owners, not juniors

You work with principals

People who have led companies and sat on boards — personalised attention, breadth of experience, no layered hierarchy.

Navigating the path

Because we’ve walked it

Grants, approvals, reimbursement, market entry — we know the regulatory, funding and commercialisation path because we’ve done it ourselves, not advised from outside.

The right path, tailored

No set formula

We solve the specific problem in front of you and shape every engagement around your organisation, its market and its stage.

How we work

Four ways in, one journey out.

Wherever you are between early innovation and commercial success, we meet you there — with advice, hands-on delivery, deal capability or board judgement.

Where we work

Across the sectors turning science into products.

From the lab bench to the point of care and the market — with founders, boards and investors right across life sciences and medtech.

Life sciences Medtech & medical devices Diagnostics & point-of-care Digital health Therapeutics & pharma Preventative health & wellness Sports & fitness Lab & clinical testing Biodiscovery Health data